ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08627
-0,04%
Bitcoin
65.401,46
0,25%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) News

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ADMA
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADMAAdma Biologics Inc
09/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
09/05/202422h05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
09/05/202413h47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:ADMAAdma Biologics Inc
02/05/202413h00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
11/03/202421h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
11/03/202417h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202412h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
09/03/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
05/03/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
05/03/202413h00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
05/03/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
29/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
28/02/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
28/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
28/02/202422h10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202422h05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
28/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
21/02/202422h05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
21/02/202413h00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202417h50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
08/01/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
08/01/202413h00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ADMA

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
DBI
SDXP
SDAX
TG
BAYN
Bayer
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
TG
LHA
Deutsche Lufthansa
NASDAQ
TSLA
Tesla
FX
EURJPY
Euro vs Yen
NASDAQ
NVDA
NVIDIA
TG
DTE
Deutsche Telekom
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
TG
TUI1
Tui
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten